These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

275 related items for PubMed ID: 21515463

  • 21. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice.
    Hasegawa H, Kohno M, Sasaki M, Inoue A, Ito MR, Terada M, Hieshima K, Maruyama H, Miyazaki J, Yoshie O, Nose M, Fujita S.
    Arthritis Rheum; 2003 Sep; 48(9):2555-66. PubMed ID: 13130475
    [Abstract] [Full Text] [Related]

  • 22. Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan.
    Keil A, Hall SR, Körner M, Herrmann M, Schmid RA, Frese S.
    Arthritis Res Ther; 2016 Oct 22; 18(1):243. PubMed ID: 27770825
    [Abstract] [Full Text] [Related]

  • 23. CXCL13 blockade attenuates lupus nephritis of MRL/lpr mice.
    Wu X, Guo J, Ding R, Lv B, Bi L.
    Acta Histochem; 2015 Oct 22; 117(8):732-7. PubMed ID: 26456520
    [Abstract] [Full Text] [Related]

  • 24. The emergence of anti-dsDNA antibodies precedes nucleosome-specific antibodies in MRL/lpr and MRL/+ mice.
    Lu Q, Kanai Y, Kubota T.
    J Med Dent Sci; 2003 Mar 22; 50(1):9-15. PubMed ID: 12715914
    [Abstract] [Full Text] [Related]

  • 25. An epistatic effect of the female specific loci on the development of autoimmune vasculitis and antinuclear autoantibody in murine lupus.
    Zhang MC, Misu N, Furukawa H, Watanabe Y, Terada M, Komori H, Miyazaki T, Nose M, Ono M.
    Ann Rheum Dis; 2006 Apr 22; 65(4):495-500. PubMed ID: 16150787
    [Abstract] [Full Text] [Related]

  • 26. Procyanidin B2 prevents lupus nephritis development in mice by inhibiting NLRP3 inflammasome activation.
    He J, Sun M, Tian S.
    Innate Immun; 2018 Jul 22; 24(5):307-315. PubMed ID: 29874961
    [Abstract] [Full Text] [Related]

  • 27. Clear suppression of Th1 responses but marginal amelioration of autoimmune manifestations by IL-12p40 transgene in MRL-FAS(lprcg)/FAS(lprcg) mice.
    Yasuda T, Yoshimoto T, Tsubura A, Matsuzawa A.
    Cell Immunol; 2001 Jun 15; 210(2):77-86. PubMed ID: 11520074
    [Abstract] [Full Text] [Related]

  • 28. High titer anti-basement membrane antibodies in a subset of patients with pediatric systemic lupus erythematosus.
    Orjuela A, Suwanichkul A, Canter D, Minard CG, Devaraj S, Hicks MJ, Muscal E, Wenderfer SE.
    Am J Nephrol; 2015 Jun 15; 41(3):241-7. PubMed ID: 25926050
    [Abstract] [Full Text] [Related]

  • 29. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.
    Jiang C, Zhao ML, Scearce RM, Diaz M.
    Arthritis Rheum; 2011 Apr 15; 63(4):1086-96. PubMed ID: 21225690
    [Abstract] [Full Text] [Related]

  • 30. Cross-reactivity of antiidiotypic antibodies with DNA in systemic lupus erythematosus.
    Eivazova ER, McDonnell JM, Sutton BJ, Staines NA.
    Arthritis Rheum; 2000 Feb 15; 43(2):429-39. PubMed ID: 10693885
    [Abstract] [Full Text] [Related]

  • 31. IK cytokine ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Muraoka M, Hasegawa H, Kohno M, Inoue A, Miyazaki T, Terada M, Nose M, Yasukawa M.
    Arthritis Rheum; 2006 Nov 15; 54(11):3591-600. PubMed ID: 17075801
    [Abstract] [Full Text] [Related]

  • 32. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
    Becker-Merok A, Kalaaji M, Haugbro K, Nikolaisen C, Nilsen K, Rekvig OP, Nossent JC.
    Arthritis Res Ther; 2006 Nov 15; 8(6):R162. PubMed ID: 17062137
    [Abstract] [Full Text] [Related]

  • 33. Erythropoietin Treatment Ameliorates Lupus Nephritis of MRL/lpr Mice.
    Zhang Z, Liu D, Zhang X, Wang X.
    Inflammation; 2018 Oct 15; 41(5):1888-1899. PubMed ID: 29951872
    [Abstract] [Full Text] [Related]

  • 34. Anti-T cell receptor antibody treatment of mice with lupus-like graft versus host disease: suppression of glomerulonephritis without reduction in anti-DNA antibody levels.
    Maeda T, Nomoto K.
    J Rheumatol; 1995 Dec 15; 22(12):2259-65. PubMed ID: 8835559
    [Abstract] [Full Text] [Related]

  • 35. [Combined mesenchymal stem cells and allogenic bone marrow transplantation in treatment of MRL/lpr mice].
    Zhang GF, Zhang X, Dong GF.
    Zhonghua Nei Ke Za Zhi; 2008 Sep 15; 47(9):754-7. PubMed ID: 19080203
    [Abstract] [Full Text] [Related]

  • 36. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
    Cai XY, Yang XY, Chen XH, Liang LQ, Guan MM, Qin SG, Fu JZ.
    Zhonghua Yi Xue Za Zhi; 2004 Sep 02; 84(17):1436-9. PubMed ID: 15500738
    [Abstract] [Full Text] [Related]

  • 37. Distinct clonotypes of anti-DNA antibodies in mice with lupus nephritis.
    Yoshida H, Yoshida M, Izui S, Lambert PH.
    J Clin Invest; 1985 Aug 02; 76(2):685-94. PubMed ID: 3875630
    [Abstract] [Full Text] [Related]

  • 38. Transplantation of umbilical cord mesenchymal stem cells alleviates lupus nephritis in MRL/lpr mice.
    Gu Z, Akiyama K, Ma X, Zhang H, Feng X, Yao G, Hou Y, Lu L, Gilkeson GS, Silver RM, Zeng X, Shi S, Sun L.
    Lupus; 2010 Nov 02; 19(13):1502-14. PubMed ID: 20647254
    [Abstract] [Full Text] [Related]

  • 39. Jak/STAT signaling is involved in the inflammatory infiltration of the kidneys in MRL/lpr mice.
    Wang S, Yang N, Zhang L, Huang B, Tan H, Liang Y, Li Y, Yu X.
    Lupus; 2010 Sep 02; 19(10):1171-80. PubMed ID: 20501525
    [Abstract] [Full Text] [Related]

  • 40. Antibodies to ribosomal P proteins: a potential serologic marker for lupus membranous glomerulonephritis.
    do Nascimento AP, Viana Vdos S, Testagrossa Lde A, Leon EP, Borba EF, Barros RT, Bonfá E.
    Arthritis Rheum; 2006 May 02; 54(5):1568-72. PubMed ID: 16645990
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.